Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma – A case report

Pembrolizumab is a monoclonal antibody against the programmed cell death 1 (PD-1) receptor, and is widely used for the treatment of various malignancies, most commonly malignant melanoma. Here we report the first documented and pathology proven case of Organizing Pneumonia complicating treatment wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuint, R., Lotem, M., Neuman, T., Bekker-Milovanov, E., Abutbul, A., Laxer, U., Berkman, N., Fridlender, Z.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247287/
https://www.ncbi.nlm.nih.gov/pubmed/28127529
http://dx.doi.org/10.1016/j.rmcr.2017.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247287/
https://www.ncbi.nlm.nih.gov/pubmed/28127529
http://dx.doi.org/10.1016/j.rmcr.2017.01.003

Ejemplares similares